ForeQube

ForeQube presents the latest analysis on the top pharma companies by global revenue in 2024 and 2025. As the pharmaceutical industry continues to evolve, 2024 proved to be a defining year for innovation, drug development, and corporate growth. The year saw major pharmaceutical giants not only maintaining their stronghold on the market but also making breakthroughs in addressing unmet medical needs. Below, we explore the top 10 pharmaceutical companies by revenue, their top-performing drugs, and the trends shaping the future of healthcare

ForeQube Ranking of Top Pharma Companies by Global Revenue (2024–2025)

Explore ForeQube’s forecast of top pharmaceutical leaders by global revenue (2024–2025). The table below highlights the world’s leading pharmaceutical companies ranked by annual revenue (USD billion).

Key Drivers Behind Pharma Revenue Growth in 2024–2025

• Oncology Dominates: Cancer therapies continue to drive massive revenue, with Merck’s Keytruda ($29.5B) and Bristol-Myers Squibb’s Eliquis ($11.4B) leading the pack.
• Vaccine Market Growth: Pfizer’s Comirnaty ($11.2B) and GSK’s Shingrix ($4.5B) show how critical vaccine innovation is post-pandemic.
• Immunology & Rare Diseases Surge: Roche’s Ocrevus ($8.2B) and Sanofi’s Dupixent ($8.6B) underscore the expansion of treatments for autoimmune conditions and neurological disorders.
• Personalized Medicine & Biologics: The rise of drugs like Skyrizi, Tagrisso, and Kisqali reflects the shift toward targeted therapies with higher efficacy and fewer side effects

The Future of Drug Development & Pharma Innovation

The next decade will bring revolutionary shifts in drug discovery, patient care, and market competition. Here’s what’s shaping the future of pharmaceuticals:

1. AI & Big Data in Drug Discovery

AI-driven research is accelerating drug discovery, cutting costs, and reducing development timelines. Companies are leveraging machine learning to identify drug targets faster and improve clinical trial designs.

2. mRNA & Next-Gen Vaccines

The success of mRNA vaccines (Comirnaty & Moderna’s Spikevax) has paved the way for personalized cancer vaccines and treatments for infectious diseases like HIV and influenza.

3. Gene & Cell Therapy Expansions

Gene-editing technologies like CRISPR are making strides, with companies investing heavily in gene therapies for rare genetic disorders and oncology applications.

4. Addressing Unmet Medical Needs

With aging populations, pharma is focusing on neurological diseases (Alzheimer’s, Parkinson’s), metabolic disorders (obesity, diabetes), and antimicrobial resistance (AMR) to tackle global health challenges.

5. Sustainable Drug Development

Pharma giants are adopting green chemistry and biodegradable drug formulations to minimize environmental impact and comply with stricter global regulations.

Conclusion

This ForeQube report on the top pharma companies by global revenue for 2024 and 2025 provides actionable insights. The pharmaceutical industry in 2025 and beyond is set to transform patient care, improve treatment accessibility, and revolutionize drug discovery. With AI-powered innovation, precision medicine, and emerging biotech therapies, the next decade will be a defining period for healthcare.

As pharma companies continue their commitment to innovation, the race is on to bring the next breakthrough therapy to patients worldwide

FDA Drug Approvals – To explore recent approvals and regulatory trends
WHO Global Health Observatory – For stats on disease burdens and unmet medical needs
ClinicalTrials.gov – For clinical trial insights and current pipeline data.

Explore our services: foreqube.com/services/